BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haga SB. Revisiting Secondary Information Related to Pharmacogenetic Testing. Front Genet 2021;12:741395. [PMID: 34659361 DOI: 10.3389/fgene.2021.741395] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jukic M, Milosavljević F, Molden E, Ingelman-Sundberg M. Pharmacogenomics in treatment of depression and psychosis: an update. Trends Pharmacol Sci 2022;43:1055-69. [PMID: 36307251 DOI: 10.1016/j.tips.2022.09.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Maruf AA, Bousman CA. Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. PCN Reports 2022;1. [DOI: 10.1002/pcn5.26] [Reference Citation Analysis]